Research programme: therapeutic cancer vaccines - Vakzine Project ManagementAlternative Names: MEL-131 IL-2/IFNγ; SK-RC-28 IL-2/IFNγ
Latest Information Update: 16 Jul 2016
At a glance
- Originator Vakzine Projekt Management
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Malignant melanoma; Renal cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Malignant-melanoma in Germany
- 16 Jul 2016 No recent reports of development identified for preclinical development in Renal-cancer in Germany
- 12 Dec 2005 Preclinical trials in Malignant melanoma in Germany (unspecified route)